TMPRSS4: a novel tumor prognostic indicator for the stratification of stage IA tumors and a liquid biopsy biomarker for NSCLC patients

TMPRSS4: a novel tumor prognostic indicator for the stratification of stage IA tumors and a liquid biopsy biomarker for NSCLC patients

Relapse rates in surgically resected non-small-cell lung cancer (NSCLC) patients are between 30% and 45% within five years of diagnosis, which shows the clinical need to identify those patients at high risk of recurrence. The eighth TNM staging system recently refined the classification of NSCLC...

Full description

Bibliographic Details
Main Authors: Villalba-Esparza, M. (María), Expósito, F. (Francisco), Pajares, M.J. (María José), Sainz, C. (Cristina), Redrado, M. (Miriam), Remirez, A. (Ana), Wistuba, I.I. (Ignacio I.), Behrens, C. (C.), Jantus-Lewintre, E. (Eloisa), Camps, C. (Carlos), Montuenga-Badia, L.M. (Luis M.), Pio, R. (Rubén), Lozano, M.D. (María Dolores), Andrea, C.E. (Carlos Eduardo) de, Calvo-González, A. (Alfonso)
Format: info:eu-repo/semantics/article
Language:eng
Published: MDPI AG 2021
Subjects:
NSCLC
TMPRSS4
Liquid biopsy
Prognosis
DNA methylation
Online Access:https://hdl.handle.net/10171/62302

Similar Items

Similar Items